RxDoctor Payments Data

Nancy Daniels, APRN

Psychiatric/Mental Health · San Antonio, TXNPI 1679664593

Payments from drug & device makers

$9,893in general payments, 2019–2025

Across 424 payments — averaging $23.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$940
  • AbbVie$839
  • Axsome Therapeutics, Inc.$823
  • Teva Pharmaceuticals USA, Inc.$817
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$805
  • Neurocrine Biosciences, Inc.$804
  • plus $5K from 24 others

What the payments were for

  • Food & beverage$9,846100%
  • Education$470%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,893 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$12,067
Medicare patients
43
Services billed
132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole29$4,765
Desvenlafaxine Succinate ErDesvenlafaxine Succinate22$2,125
Duloxetine Hcl36$1,641
Clonazepam45$1,303
Bupropion XlBupropion Hcl39$1,247
Quetiapine Fumarate60$1,115
Venlafaxine Hcl ErVenlafaxine Hcl19$894
Ziprasidone Hcl13$823
Oxcarbazepine17$629
Lamotrigine22$446
Alprazolam53$440
Gabapentin16$270
Escitalopram Oxalate18$270
Trazodone Hcl27$225
Zolpidem Tartrate13$208

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →